The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In Vitro Colorectal Cancer Testing Market Research Report 2025
Synopsis
Screening for colorectal cancer allows for the early detection of cancer when it is highly curable, as well as the detection of growths (polyps) that might eventually become cancer.
The global In Vitro Colorectal Cancer Testing market was valued at US$ 851.2 million in 2023 and is anticipated to reach US$ 1062.4 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
North American market for In Vitro Colorectal Cancer Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Vitro Colorectal Cancer Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for In Vitro Colorectal Cancer Testing in Ambulatory Surgical Centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of In Vitro Colorectal Cancer Testing include Abbott Laboratories, BioTime, Danaher Corporation, Epigenomics AG, Exact Sciences Corporation, LifeLabs Medical Laboratory Services, Novigenix SA, Quest Diagnostics and Sysmex Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vitro Colorectal Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Colorectal Cancer Testing.
Report Scope
The In Vitro Colorectal Cancer Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Colorectal Cancer Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Colorectal Cancer Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
BioTime
Danaher Corporation
Epigenomics AG
Exact Sciences Corporation
LifeLabs Medical Laboratory Services
Novigenix SA
Quest Diagnostics
Sysmex Corporation
Segment by Type
Fecal Occult Blood Tests
Stool Biomarkers Tests
Blood Biomarker Tests
Segment by Application
Ambulatory Surgical Centers
Hospitals
Physical Examination Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Colorectal Cancer Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Screening for colorectal cancer allows for the early detection of cancer when it is highly curable, as well as the detection of growths (polyps) that might eventually become cancer.
The global In Vitro Colorectal Cancer Testing market was valued at US$ 851.2 million in 2023 and is anticipated to reach US$ 1062.4 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
North American market for In Vitro Colorectal Cancer Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Vitro Colorectal Cancer Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for In Vitro Colorectal Cancer Testing in Ambulatory Surgical Centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of In Vitro Colorectal Cancer Testing include Abbott Laboratories, BioTime, Danaher Corporation, Epigenomics AG, Exact Sciences Corporation, LifeLabs Medical Laboratory Services, Novigenix SA, Quest Diagnostics and Sysmex Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vitro Colorectal Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Colorectal Cancer Testing.
Report Scope
The In Vitro Colorectal Cancer Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Colorectal Cancer Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Colorectal Cancer Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
BioTime
Danaher Corporation
Epigenomics AG
Exact Sciences Corporation
LifeLabs Medical Laboratory Services
Novigenix SA
Quest Diagnostics
Sysmex Corporation
Segment by Type
Fecal Occult Blood Tests
Stool Biomarkers Tests
Blood Biomarker Tests
Segment by Application
Ambulatory Surgical Centers
Hospitals
Physical Examination Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Colorectal Cancer Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Colorectal Cancer Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fecal Occult Blood Tests
1.2.3 Stool Biomarkers Tests
1.2.4 Blood Biomarker Tests
1.3 Market by Application
1.3.1 Global In Vitro Colorectal Cancer Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Ambulatory Surgical Centers
1.3.3 Hospitals
1.3.4 Physical Examination Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Colorectal Cancer Testing Market Perspective (2019-2030)
2.2 In Vitro Colorectal Cancer Testing Growth Trends by Region
2.2.1 Global In Vitro Colorectal Cancer Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro Colorectal Cancer Testing Historic Market Size by Region (2019-2024)
2.2.3 In Vitro Colorectal Cancer Testing Forecasted Market Size by Region (2025-2030)
2.3 In Vitro Colorectal Cancer Testing Market Dynamics
2.3.1 In Vitro Colorectal Cancer Testing Industry Trends
2.3.2 In Vitro Colorectal Cancer Testing Market Drivers
2.3.3 In Vitro Colorectal Cancer Testing Market Challenges
2.3.4 In Vitro Colorectal Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Colorectal Cancer Testing Players by Revenue
3.1.1 Global Top In Vitro Colorectal Cancer Testing Players by Revenue (2019-2024)
3.1.2 Global In Vitro Colorectal Cancer Testing Revenue Market Share by Players (2019-2024)
3.2 Global In Vitro Colorectal Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Colorectal Cancer Testing Revenue
3.4 Global In Vitro Colorectal Cancer Testing Market Concentration Ratio
3.4.1 Global In Vitro Colorectal Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Colorectal Cancer Testing Revenue in 2023
3.5 In Vitro Colorectal Cancer Testing Key Players Head office and Area Served
3.6 Key Players In Vitro Colorectal Cancer Testing Product Solution and Service
3.7 Date of Enter into In Vitro Colorectal Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Colorectal Cancer Testing Breakdown Data by Type
4.1 Global In Vitro Colorectal Cancer Testing Historic Market Size by Type (2019-2024)
4.2 Global In Vitro Colorectal Cancer Testing Forecasted Market Size by Type (2025-2030)
5 In Vitro Colorectal Cancer Testing Breakdown Data by Application
5.1 Global In Vitro Colorectal Cancer Testing Historic Market Size by Application (2019-2024)
5.2 Global In Vitro Colorectal Cancer Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vitro Colorectal Cancer Testing Market Size (2019-2030)
6.2 North America In Vitro Colorectal Cancer Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vitro Colorectal Cancer Testing Market Size by Country (2019-2024)
6.4 North America In Vitro Colorectal Cancer Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Colorectal Cancer Testing Market Size (2019-2030)
7.2 Europe In Vitro Colorectal Cancer Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vitro Colorectal Cancer Testing Market Size by Country (2019-2024)
7.4 Europe In Vitro Colorectal Cancer Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Colorectal Cancer Testing Market Size (2019-2030)
8.2 Asia-Pacific In Vitro Colorectal Cancer Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vitro Colorectal Cancer Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vitro Colorectal Cancer Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Colorectal Cancer Testing Market Size (2019-2030)
9.2 Latin America In Vitro Colorectal Cancer Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vitro Colorectal Cancer Testing Market Size by Country (2019-2024)
9.4 Latin America In Vitro Colorectal Cancer Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Colorectal Cancer Testing Market Size (2019-2030)
10.2 Middle East & Africa In Vitro Colorectal Cancer Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vitro Colorectal Cancer Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vitro Colorectal Cancer Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories In Vitro Colorectal Cancer Testing Introduction
11.1.4 Abbott Laboratories Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 BioTime
11.2.1 BioTime Company Detail
11.2.2 BioTime Business Overview
11.2.3 BioTime In Vitro Colorectal Cancer Testing Introduction
11.2.4 BioTime Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.2.5 BioTime Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Detail
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation In Vitro Colorectal Cancer Testing Introduction
11.3.4 Danaher Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.3.5 Danaher Corporation Recent Development
11.4 Epigenomics AG
11.4.1 Epigenomics AG Company Detail
11.4.2 Epigenomics AG Business Overview
11.4.3 Epigenomics AG In Vitro Colorectal Cancer Testing Introduction
11.4.4 Epigenomics AG Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.4.5 Epigenomics AG Recent Development
11.5 Exact Sciences Corporation
11.5.1 Exact Sciences Corporation Company Detail
11.5.2 Exact Sciences Corporation Business Overview
11.5.3 Exact Sciences Corporation In Vitro Colorectal Cancer Testing Introduction
11.5.4 Exact Sciences Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.5.5 Exact Sciences Corporation Recent Development
11.6 LifeLabs Medical Laboratory Services
11.6.1 LifeLabs Medical Laboratory Services Company Detail
11.6.2 LifeLabs Medical Laboratory Services Business Overview
11.6.3 LifeLabs Medical Laboratory Services In Vitro Colorectal Cancer Testing Introduction
11.6.4 LifeLabs Medical Laboratory Services Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.6.5 LifeLabs Medical Laboratory Services Recent Development
11.7 Novigenix SA
11.7.1 Novigenix SA Company Detail
11.7.2 Novigenix SA Business Overview
11.7.3 Novigenix SA In Vitro Colorectal Cancer Testing Introduction
11.7.4 Novigenix SA Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.7.5 Novigenix SA Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Detail
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics In Vitro Colorectal Cancer Testing Introduction
11.8.4 Quest Diagnostics Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.8.5 Quest Diagnostics Recent Development
11.9 Sysmex Corporation
11.9.1 Sysmex Corporation Company Detail
11.9.2 Sysmex Corporation Business Overview
11.9.3 Sysmex Corporation In Vitro Colorectal Cancer Testing Introduction
11.9.4 Sysmex Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024)
11.9.5 Sysmex Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global In Vitro Colorectal Cancer Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fecal Occult Blood Tests
Table 3. Key Players of Stool Biomarkers Tests
Table 4. Key Players of Blood Biomarker Tests
Table 5. Global In Vitro Colorectal Cancer Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global In Vitro Colorectal Cancer Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global In Vitro Colorectal Cancer Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global In Vitro Colorectal Cancer Testing Market Share by Region (2019-2024)
Table 9. Global In Vitro Colorectal Cancer Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global In Vitro Colorectal Cancer Testing Market Share by Region (2025-2030)
Table 11. In Vitro Colorectal Cancer Testing Market Trends
Table 12. In Vitro Colorectal Cancer Testing Market Drivers
Table 13. In Vitro Colorectal Cancer Testing Market Challenges
Table 14. In Vitro Colorectal Cancer Testing Market Restraints
Table 15. Global In Vitro Colorectal Cancer Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global In Vitro Colorectal Cancer Testing Market Share by Players (2019-2024)
Table 17. Global Top In Vitro Colorectal Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Colorectal Cancer Testing as of 2023)
Table 18. Ranking of Global Top In Vitro Colorectal Cancer Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by In Vitro Colorectal Cancer Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players In Vitro Colorectal Cancer Testing Product Solution and Service
Table 22. Date of Enter into In Vitro Colorectal Cancer Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In Vitro Colorectal Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global In Vitro Colorectal Cancer Testing Revenue Market Share by Type (2019-2024)
Table 26. Global In Vitro Colorectal Cancer Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global In Vitro Colorectal Cancer Testing Revenue Market Share by Type (2025-2030)
Table 28. Global In Vitro Colorectal Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global In Vitro Colorectal Cancer Testing Revenue Market Share by Application (2019-2024)
Table 30. Global In Vitro Colorectal Cancer Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global In Vitro Colorectal Cancer Testing Revenue Market Share by Application (2025-2030)
Table 32. North America In Vitro Colorectal Cancer Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America In Vitro Colorectal Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America In Vitro Colorectal Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe In Vitro Colorectal Cancer Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe In Vitro Colorectal Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe In Vitro Colorectal Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific In Vitro Colorectal Cancer Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific In Vitro Colorectal Cancer Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific In Vitro Colorectal Cancer Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America In Vitro Colorectal Cancer Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America In Vitro Colorectal Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America In Vitro Colorectal Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa In Vitro Colorectal Cancer Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa In Vitro Colorectal Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa In Vitro Colorectal Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories In Vitro Colorectal Cancer Testing Product
Table 50. Abbott Laboratories Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. BioTime Company Detail
Table 53. BioTime Business Overview
Table 54. BioTime In Vitro Colorectal Cancer Testing Product
Table 55. BioTime Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 56. BioTime Recent Development
Table 57. Danaher Corporation Company Detail
Table 58. Danaher Corporation Business Overview
Table 59. Danaher Corporation In Vitro Colorectal Cancer Testing Product
Table 60. Danaher Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 61. Danaher Corporation Recent Development
Table 62. Epigenomics AG Company Detail
Table 63. Epigenomics AG Business Overview
Table 64. Epigenomics AG In Vitro Colorectal Cancer Testing Product
Table 65. Epigenomics AG Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 66. Epigenomics AG Recent Development
Table 67. Exact Sciences Corporation Company Detail
Table 68. Exact Sciences Corporation Business Overview
Table 69. Exact Sciences Corporation In Vitro Colorectal Cancer Testing Product
Table 70. Exact Sciences Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 71. Exact Sciences Corporation Recent Development
Table 72. LifeLabs Medical Laboratory Services Company Detail
Table 73. LifeLabs Medical Laboratory Services Business Overview
Table 74. LifeLabs Medical Laboratory Services In Vitro Colorectal Cancer Testing Product
Table 75. LifeLabs Medical Laboratory Services Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 76. LifeLabs Medical Laboratory Services Recent Development
Table 77. Novigenix SA Company Detail
Table 78. Novigenix SA Business Overview
Table 79. Novigenix SA In Vitro Colorectal Cancer Testing Product
Table 80. Novigenix SA Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 81. Novigenix SA Recent Development
Table 82. Quest Diagnostics Company Detail
Table 83. Quest Diagnostics Business Overview
Table 84. Quest Diagnostics In Vitro Colorectal Cancer Testing Product
Table 85. Quest Diagnostics Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 86. Quest Diagnostics Recent Development
Table 87. Sysmex Corporation Company Detail
Table 88. Sysmex Corporation Business Overview
Table 89. Sysmex Corporation In Vitro Colorectal Cancer Testing Product
Table 90. Sysmex Corporation Revenue in In Vitro Colorectal Cancer Testing Business (2019-2024) & (US$ Million)
Table 91. Sysmex Corporation Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vitro Colorectal Cancer Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global In Vitro Colorectal Cancer Testing Market Share by Type: 2023 VS 2030
Figure 3. Fecal Occult Blood Tests Features
Figure 4. Stool Biomarkers Tests Features
Figure 5. Blood Biomarker Tests Features
Figure 6. Global In Vitro Colorectal Cancer Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global In Vitro Colorectal Cancer Testing Market Share by Application: 2023 VS 2030
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Physical Examination Center Case Studies
Figure 11. In Vitro Colorectal Cancer Testing Report Years Considered
Figure 12. Global In Vitro Colorectal Cancer Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global In Vitro Colorectal Cancer Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global In Vitro Colorectal Cancer Testing Market Share by Region: 2023 VS 2030
Figure 15. Global In Vitro Colorectal Cancer Testing Market Share by Players in 2023
Figure 16. Global Top In Vitro Colorectal Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Colorectal Cancer Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by In Vitro Colorectal Cancer Testing Revenue in 2023
Figure 18. North America In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America In Vitro Colorectal Cancer Testing Market Share by Country (2019-2030)
Figure 20. United States In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe In Vitro Colorectal Cancer Testing Market Share by Country (2019-2030)
Figure 24. Germany In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific In Vitro Colorectal Cancer Testing Market Share by Region (2019-2030)
Figure 32. China In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America In Vitro Colorectal Cancer Testing Market Share by Country (2019-2030)
Figure 40. Mexico In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa In Vitro Colorectal Cancer Testing Market Share by Country (2019-2030)
Figure 44. Turkey In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia In Vitro Colorectal Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 47. BioTime Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 48. Danaher Corporation Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 49. Epigenomics AG Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 50. Exact Sciences Corporation Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 51. LifeLabs Medical Laboratory Services Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 52. Novigenix SA Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 53. Quest Diagnostics Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 54. Sysmex Corporation Revenue Growth Rate in In Vitro Colorectal Cancer Testing Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
